Skip to content

Enovis ENOV Enterprise value

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.74B-12.7%
ESAB logo
ESABESAB
$7.02B-11.5%
Vericel logo
VericelVCEL
$1.62B-28.0%
Globus Medical logo
Globus MedicalGMED
$11.21B+15.6%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Calculated from Enovis’s reported figures.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's enterprise value?
Enovis (ENOV) reported enterprise value of $2.62B in Q1 2026.
How has Enovis's enterprise value changed year-over-year?
Enovis's enterprise value decreased by 25.8% year-over-year, from $3.53B to $2.62B.
What is the long-term trend for Enovis's enterprise value?
Over 5 years (2020 to 2025), Enovis's enterprise value has grown at a -12.1% compound annual growth rate (CAGR), from $5.46B to $2.87B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.